A hospital in Tel Aviv claims it has developed a treatment that saw patients with moderate to serious COVID-19 cases leaving the hospital just days later.
Ichilov Medical Center in Tel Aviv has completed its phase one trials with its new coronavirus treatment. The EXO-CD24 treatment was given to 30 patients and all 30 recovered — 29 of them left in merely days, fully recovered, as reported by the Times of Israel.
The Times reports that the new drug fights the “cytokine storm” which is an overreaction by the body’s immune system when infected with COVID.
The treatment delivers CD24 protein to the lungs, a topic the drug’s creator, Nadir Arber, has studied for years.
“This protein is located on the surface of cells and has a well known and important role in regulating the immune system,” researcher Shiran Shapira told the Times.
This protein helps to slow the internal storm and calm the immune system.
“The preparation is inhaled once a day for a few minutes, for five days,” drug creator Nadir Arber said. “The preparation is directed straight to the heart of the storm — the lungs — so unlike other formulas… which selectively restrain a certain cytokine, or operate widely but cause many serious side effects, EXO-CD24 is administered locally, works broadly and without side effects.”
Read more about the new treatment here.